Healios K.K. (HLOSF) Financials

HLOSF Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 141.1 million 87.4 million
March 31, 2026 147.9 million 100.2 million
Dec. 31, 2025 109.0 million 77.7 million
Sept. 30, 2025 118.7 million 98.5 million

HLOSF Free Cash Flow and Stock based compensation

No data available :(

HLOSF Net Income

No data available :(

HLOSF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 55.4 million 4.9 million 2.3 million
March 31, 2026 68.5 million 10.1 million 2.5 million
Dec. 31, 2025 36.3 million 12.9 million 3.6 million
Sept. 30, 2025 44.5 million 14.0 million 3.1 million

HLOSF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 830050
March 31, 2026 787533
Dec. 31, 2025 651727
Sept. 30, 2025 780084

HLOSF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 585981 5.7 million 1.7 million -
March 31, 2026 226798 5.0 million 1.8 million -
Dec. 31, 2025 594164 3.1 million 2.5 million -
Sept. 30, 2025 398646 3.2 million 1.4 million -

HLOSF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 42727 421174
March 31, 2026 50399 440997
Dec. 31, 2025 159721 945551
Sept. 30, 2025 130215 774420

HLOSF

Price: $1.80

52 week price:
1.80
4.45

Earnings Per Share: 0.01 USD

P/E Ratio: 180

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 243.0 million

Links: